Product Information
MOXIFLOXACIN 0.5% EYE DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.5963 per ML under NDC 62332050503. Its NADAC has been published 389 times since Apr 24, 2019.
FDA first approved this application on Feb 13, 2019. Its Orange Book therapeutic-equivalence code is AT1.
Strength
5 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050503
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
MOXIFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209469FDA Approved
2/13/2019
TE Code
AT1
On Market Since
2/13/2019
Pharmacological Classes
Price Statistics
The NADAC for MOXIFLOXACIN 0.5% EYE DROPS has been published 389 times since Apr 24, 2019, and over the history we have for it it has declined 77.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5963 per ML |
|---|---|
| All-time high | $7.6914 (Jun 12, 2019) |
| All-time low | $1.5386 (Aug 19, 2026) |
| 52-week high | $1.8460 |
| 52-week low | $1.5386 |
| Median price | $3.4137 |
| Average price | $3.9228 |
| Largest weekly change | +41.1% (Nov 23, 2022) |
| Weeks tracked | 389 |
| Tracking since | Apr 24, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Moxifloxacin ophthalmic solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Moxifloxacin ophthalmic solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOXIFLOXACIN 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for MOXIFLOXACIN 0.5% EYE DROPS, manufactured by Alembic Pharmaceuticals Inc., is $1.5963 per ML (NDC 62332050503), effective Sep 30, 2026.
How has the price of MOXIFLOXACIN 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has declined 77.2%. It has been tracked across 389 weekly CMS publications since Apr 24, 2019.
What are the highest and lowest recorded NADAC prices for MOXIFLOXACIN 0.5% EYE DROPS?
Since Apr 24, 2019, the NADAC for MOXIFLOXACIN 0.5% EYE DROPS has ranged from a low of $1.5386 (Aug 19, 2026) to a high of $7.6914 (Jun 12, 2019), with a median of $3.4137 per ML.
Are there cheaper alternatives to MOXIFLOXACIN 0.5% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of MOXIFLOXACIN 0.5% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MOXIFLOXACIN 0.5% EYE DROPS?
MOXIFLOXACIN 0.5% EYE DROPS (NDC 62332050503) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.